what do glp-1 agonists do Can one drug it all? Reviewing the expanding clinical universe of what does glp 1 GLP-1

Description

Clinical pharmacology biopharmaceutics review: Byetta

At present 33% of US adults are overweight and are in the 40-59 age group

A 2023 study revealed that theres a slightly increased risk for intestinal obstruction (when your intestines cant contract, making it hard to get rid of waste), because semaglutide slows down food as it travels through your digestive system (17)

(average results) Wegovy (semaglutide) GLP-1 only In the STEP-1 study (68 weeks), average weight change was about: 14.9% with Wegovy 2.4% with placebo (dummy injection) What that looks like: If you start at 100 kg , 14.9% is about 15 kg lost on average